Mechanism
How restless legs syndrome works
Four chapters, built from the same graded evidence used across this site, tracing restless legs syndrome from a local iron shortfall in the brain to the urge to move your legs at night.
Restless legs syndrome is driven by a local brain iron shortfall that disrupts dopamine signalling, an evening dip that lands harder on an already-weakened system, and resulting hyperarousal and spinal hyperexcitability. Each stage below carries its own evidence grade and citation.
The 3D figures below are simplified, illustrative schematics of mechanism — not medical imaging, and not evidence on their own. Every claim they visualize is cited separately, with an evidence grade, in the list beside it.
Chapter 1 of 4
Iron does not reach the brain
Not the iron your blood count measures — a local shortfall in the brain regions that control movement.
It starts with iron — but not the iron in your blood count. The best-supported explanation is that the brain regions controlling movement do not hold on to iron as they should. You can be entirely non-anaemic and still be short where it matters. Iron is the cofactor the brain needs to make dopamine, so a local shortage quietly changes how dopamine signalling behaves.
The genes that carry RLS risk in families — MEIS1, BTBD9, PTPRD — are iron-handling and neural-development genes, which is part of why RLS runs in families and why the tendency does not disappear after a course of iron tablets. Knowledge-base synthesis work points to a transport bottleneck rather than a simple supply shortage: iron acquisition across the blood-brain barrier looks impaired at the receptor level itself, so the brain can stay short even when a peripheral blood test looks normal.
Honesty note: this is the field's working model, not a settled fact. The largest MRI study to date, pooled with everything published before it, found no overall evidence of lower brain iron in RLS — with signs of publication bias in the older literature. Cerebrospinal-fluid and autopsy evidence still support brain iron deficiency; the in-vivo imaging picture is the contested part. Strong hypothesis, contested measurement.
What the evidence says
- CCSF ferritin is reduced and CSF transferrin elevated in idiopathic RLS, despite normal serum ferritin and transferrin — the original biochemical evidence for brain-specific iron deficiency. PMID 10762522
- CAutopsy studies of the substantia nigra show a coordinated iron-handling defect: decreased ferritin, DMT1, ferroportin and transferrin receptor in the very cells that make dopamine. PMID 15136682
- BA randomized, placebo-controlled trial of IV iron (ferric carboxymaltose) produced significantly greater symptom improvement at 6 weeks, paired with MRI-measurable increases in brain iron. PMID 37437492
- DThe AASM 2024/2025 clinical guideline recommends checking ferritin and transferrin saturation in everyone with clinically significant RLS, with a strong recommendation for IV iron below its threshold. PMID 39324694
- AContested: the largest MRI study to date, plus a formal meta-analysis of everything before it, found no pooled evidence of lower brain iron in RLS, and flagged likely publication bias in the earlier literature. PMID 35500370
A schematic cross-section of iron transport across the blood-brain barrier: transferrin carries iron across, ferritin stores it, and the iron-dependent enzyme tyrosine hydroxylase uses it to make dopamine. Toggle to compare a healthy state against brain iron deficiency. (Healthy)
A schematic cross-section of iron transport across the blood-brain barrier: transferrin carries iron across, ferritin stores it, and the iron-dependent enzyme tyrosine hydroxylase uses it to make dopamine. Toggle to compare a healthy state against brain iron deficiency.
Chapter 2 of 4
The dopamine paradox
Not a deficiency like Parkinson's — a system running too hot by day and crashing at night.
Then dopamine goes out of rhythm — not simply "low." RLS is not a dopamine deficiency like Parkinson's; that is the thing patients are most often told wrongly. It looks more like a system running too hot by day and crashing in the evening: more dopamine made and released, and in response the receiving side turns its own receptors down.
Autopsy tissue shows this paradox directly — increased tyrosine hydroxylase (the iron-dependent enzyme that makes dopamine) alongside decreased D2-receptor density, and the receptor loss tracks with how severe symptoms are. Dopamine dips at night in everyone, but in a system whose receptors have already turned down, that ordinary dip lands much harder — which is why symptoms obey the clock rather than simply how tired you are.
This is also why dopaminergic drugs work, at first, so convincingly — and why that is a double-edged fact. Levodopa and D2/D3 agonists produce large, repeatedly replicated reductions in symptoms and leg movements; it is the single most robust evidence that the dopamine system is centrally involved. But keeping that system artificially topped up for years, without the iron shortfall underneath it corrected, is part of the setup that lets augmentation take hold — the subject of the next page.
What the evidence says
- AA Cochrane systematic review of 9 randomized trials (n=521) found levodopa significantly reduces RLS symptoms and periodic limb movements. PMID 21328278
- BA 344-patient, placebo-controlled trial found pramipexole reduced RLS severity scores across every dose tested. PMID 16931507
- CAutopsy tissue shows increased tyrosine hydroxylase alongside decreased D2-receptor density in the substantia nigra and putamen, correlating with disease severity. PMID 19467991
- CA large community cohort found dopamine-agonist augmentation compounds over time — roughly 8% per year for at least 8 years. PMID 21493132
A dopaminergic synapse cross-section: a presynaptic terminal releasing dopamine, a reuptake transporter, and postsynaptic receptors, alongside a tyrosine-hydroxylase/iron gauge. Toggle to compare a healthy synapse against the iron-deficient, receptor-downregulated state. (Healthy)
A dopaminergic synapse cross-section: a presynaptic terminal releasing dopamine, a reuptake transporter, and postsynaptic receptors, alongside a tyrosine-hydroxylase/iron gauge. Toggle to compare a healthy synapse against the iron-deficient, receptor-downregulated state.
Chapter 3 of 4
Evening: the circadian dip and hyperarousal
The system is over-aroused and under-braked, and it obeys the clock, not just tiredness.
And the whole system is over-aroused and under-braked. Adenosine — the brain's own "slow down" signal, the one caffeine blocks — appears to work weakly at its A1 receptors in RLS, leaving glutamate, the accelerator, unopposed. That is the arousal half of RLS: the reason your mind is wide awake at 23:00 as well as your legs.
This shows up as measurable cortical hyperexcitability, not just a subjective feeling: a systematic review pooling 21 studies (319 RLS patients, 278 controls) found reduced inhibitory tone in the motor cortex to be the single most consistent finding in the whole RLS electrophysiology literature — and it is worse specifically at night, not during the day.
The clock drives it, not just accumulated tiredness. Controlled studies that hold body position and sleep state constant across a full 24 hours still find an independent circadian effect on symptoms — worst around midnight to 1am, easiest around 9-11am. Endogenous melatonin's evening rise is the marker that best predicts the coming worsening, by about two hours — part of why taking extra melatonin as a sleep aid is specifically flagged as the wrong tool in this condition.
Why evening?
Melatonin's evening rise inhibits central dopamine release. In a system whose receptors are already turned down (previous chapter), that ordinary nightly dip lands far harder — and, independently, cortical and spinal inhibitory tone are both at their weakest during the very same hours.
What the evidence says
- AA systematic review of 21 TMS studies found reduced short-interval intracortical inhibition to be the single most reproducible electrophysiological abnormality in RLS. PMID 39626363
- BA placebo-controlled crossover trial of dipyridamole (which raises extracellular adenosine) significantly improved symptoms and objective arousal/sleep measures. PMID 34137476
- CA 28-hour constant-routine study (posture, light and feeding held constant) found endogenous melatonin's rise is the one marker that reliably precedes RLS symptom worsening, by roughly two hours. PMID 14991815
- BIn a controlled, within-subject crossover study of eight people, 3 mg of melatonin taken in the evening significantly worsened objectively measured leg movements versus baseline and versus bright light. PMID 20226733
A whole-brain overview highlighting the substantia nigra, striatum, thalamus and the A11 pathway descending toward the spinal cord, shown here in the iron-deficient state: dimmed nigral/striatal tone and a flickering thalamus depict the evening hyperarousal described alongside it. (Iron-deficient)
A whole-brain overview highlighting the substantia nigra, striatum, thalamus and the A11 pathway descending toward the spinal cord, shown here in the iron-deficient state: dimmed nigral/striatal tone and a flickering thalamus depict the evening hyperarousal described alongside it.
Chapter 4 of 4
From spinal cord to legs: urge waves and PLMS
Where the urge to move, and the movements themselves, are actually generated.
Put the three together — iron, mistimed dopamine, unbraked arousal — and the spinal cord's own reflex circuits become hyperexcitable. That is where the leg movements and the irresistible urge to move are actually generated, under descending inhibitory control from the brain that has weakened.
Movement relieves the urge, briefly, because it feeds sensory input back into those same circuits — not because anything has been fixed. Each periodic limb movement in sleep (PLMS) is also a small autonomic event: a brief surge in heart rate and blood pressure, larger in RLS than in healthy sleepers, which is one reason the movement burden is tracked as more than a comfort issue.
Leg-specific oxygen delivery also falls during long stretches of immobility, tracking symptom severity and partially reversing with dopaminergic treatment — a peripheral layer on top of the central story, and part of why the plan's evening toolkit warns against long motionless stretches regardless of what else is being done.
What the evidence says
- BThe spinal flexor-withdrawal reflex is hyperexcitable and state-dependent (worse during sleep) in RLS/PLMS, a finding replicated in secondary, uremic RLS. PMID 10762502
- BEach individual PLMS event triggers a measurable surge in heart rate and blood pressure, significantly larger in RLS patients than in healthy controls. PMID 23643655
- AA meta-analysis of 6 studies found PLMS carriers have significantly higher rates of coronary artery disease and cardiovascular disease overall. PMID 29952124
- BPeripheral leg-specific hypoxia occurs during enforced immobility in RLS, scales with symptom severity, and is partially reversed by pramipexole. PMID 24789861
A simplified spinal cord and right leg: the A11 pathway descends from the cord, sensory nerves run the other way from the leg, and pulses travel up as "urge waves" with a periodic foot twitch depicting PLMS. Toggle to compare a quiet, healthy state against the iron-deficient state where urge waves and twitches appear. (Healthy)
A simplified spinal cord and right leg: the A11 pathway descends from the cord, sensory nerves run the other way from the leg, and pulses travel up as "urge waves" with a periodic foot twitch depicting PLMS. Toggle to compare a quiet, healthy state against the iron-deficient state where urge waves and twitches appear.
Terms used on this page
Glossary
- RLS (restless legs syndrome)
- A chronic neurological condition causing an urge to move the legs, usually with an uncomfortable sensation — worse at rest and in the evening, eased by movement.
- Brain iron deficiency
- A local shortage of iron in the brain regions that control movement, which can be present even when a standard blood test looks entirely normal.
- Ferritin / TSAT
- Blood markers used to estimate the body's iron stores. Guidelines use ferritin and transferrin saturation (TSAT) thresholds to decide whether iron treatment is warranted.
- Dopamine agonist
- A class of drugs — pramipexole, ropinirole, rotigotine — that mimic dopamine's effect on its receptors. Commonly the first medication prescribed for RLS.
- Augmentation
- A drug-driven worsening of RLS that can develop on long-term dopamine-agonist treatment: symptoms start earlier in the day, spread to other body parts, and intensify — it is not the underlying disease progressing on its own.
- DAWS (dopamine-agonist withdrawal syndrome)
- A severe reaction some people have when a dopamine agonist is reduced or stopped, with no proven effective treatment. The reason any tapering must be slow and physician-supervised, never abrupt.
- Alpha-2-delta ligand
- A different drug class — gabapentin, pregabalin, gabapentin enacarbil — that acts on calcium channels and glutamate release rather than dopamine; usually the destination when moving away from an agonist.
- PLMS (periodic limb movements in sleep)
- Repetitive leg jerks during sleep, generated by hyperexcitable spinal reflex circuits, often measured alongside RLS as an objective severity marker.
- Adenosine / A1 receptor
- The brain's own "slow down" signal — the one caffeine blocks. It appears to work weakly at its A1 receptors in RLS, leaving the brain's "accelerator" signal, glutamate, unopposed.
- IRLS
- The International Restless Legs Scale: a 0-40 point questionnaire clinicians use to score symptom severity and track it over time.
Go deeper
The full evidence behind each chapter
Answers, cited
Related questions
A few questions this page's own FAQ set answers directly:
What is restless legs syndrome (RLS)?
RLS is a chronic neurological condition causing an urge to move the legs, usually with an uncomfortable sensation, that is worse at rest, worse in the evening or night, and relieved by movement. Diagnosis requires five essential criteria, including ruling out other conditions that could explain the symptoms.
Evidence: D — IRLSSG diagnostic criteria, PMID 25023924
Why are restless legs symptoms worse at night?
RLS follows the body clock, not just tiredness. Cortical and spinal inhibitory tone are both weakest at night, and dopamine's evening dip lands harder on a system whose receptors are already turned down. Endogenous melatonin's evening rise is the marker that best predicts the coming worsening, by about two hours.
Evidence: A for cortical hyperexcitability, PMID 39626363; C for the melatonin-timing finding, PMID 14991815
What causes restless legs syndrome?
The leading hypothesis is a local brain iron shortfall — not the iron measured in a standard blood count — that disrupts dopamine signalling in movement-control regions. Autopsy and spinal-fluid studies support this; the largest brain-MRI study to date did not confirm it, so it remains the field's strongest working hypothesis rather than a settled fact.
Evidence: C for CSF/autopsy findings, PMID 10762522 and 15136682; A for the contested MRI finding, PMID 35500370
Can you have restless legs syndrome with normal blood iron levels?
Yes. Brain iron deficiency in RLS is believed to be local to the brain regions controlling movement, and can be present even when standard blood tests — including serum ferritin — look entirely normal. This is why guidelines set an RLS-specific ferritin threshold (75 ng/mL) that is much higher than the general anemia threshold.
Evidence: C, PMID 10762522; D for the guideline threshold, PMID 39324694